Northwire Canada EditionWednesday, July 15, 2026
Northwire
EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0%
Financings

Comprehensive Healthcare Systems Announces Closing of First Tranche of Private Placement

CHS · Price

Executive Summary

  • Comprehensive Healthcare Systems Inc. closed the first tranche of its non‑brokered private placement, issuing 7 million units at $0.50 per unit for total gross proceeds of $3.5 million.
  • Each unit consisted of one common share and half a warrant (full warrant exercisable at $1.00 per share for three years).
  • An insider purchased 945,000 units (~13.5% of the tranche), representing roughly 3.8% of outstanding shares; related‑party transaction exemptions under TSXV MI 61‑101 were relied upon.

Key Details

  • Units Issued: 7,000,000 at $0.50 per unit → Gross Proceeds: $3,500,000.
  • Unit Composition: 1 common share + ½ warrant (full warrant exercisable at $1.00/share, three‑year term).
  • Finder Compensation: PowerOne Capital Markets Limited received cash fees of $214,200 and was issued 428,400 finder warrants (exercise price $0.50, three‑year term).
  • Hold Period: All securities subject to a hold period until June 11 2026.
  • Insider Participation: Insider bought 945,000 units (13.5% of tranche); common shares represent ~3.8% of outstanding shares; deemed exercised warrants would increase ownership to ~5.6%.
  • Regulatory Exemptions: Transaction qualifies as a “related party transaction” under TSXV MI 61‑101; exemptions from formal valuation and minority shareholder approval were applied because the consideration does not exceed 25% of market capitalization and no securities are listed on excluded exchanges.
  • Use of Proceeds: (Not explicitly stated in release – typical use includes working capital, product development, and general corporate purposes).

Notable Quotes

“We are pleased to have successfully closed the first tranche of our private placement, which provides us with additional capital to accelerate growth initiatives and enhance our SaaS platform.” – Chris Cosgrove, Chief Executive Officer


All boilerplate, forward‑looking disclaimer, and “About the Company” sections have been omitted for brevity.

Read the original news release →

More from Comprehensive Healthcare Systems Inc.